New Line of HIV Treatment Identified for Patients Ineligible for Efavirenz
December 21st 2014A national clinical trial has found non-efavirenz antiretroviral therapy effective as a first-line treatment, which is good news for patients with HIV who are ineligible to usea the common drug.
Read More
Tenofovir Plus Interferon Improves Antigen Clearance in Chronic Hepatitis B
December 13th 2014Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. Further, with longer therapy duration improved results.
Read More
DNA Sequencing Could Lead to More Accurate Pneumonia Diagnosis
December 2nd 2014A team of researchers at George Washington University has reported that next-generation sequencing of sputum samples taken from patients in the intensive care unit can accurately identify the strain of ventilator-associated pneumonia a patient is infected with.
Read More
Triple Therapy for Hepatitis C Infection: Bacterial Infection Risk Rises, Changes
December 1st 2014Patients who have HCV infection are at high risk for arthralgia, myalgias, pruritus, neuropathy, and decompensated livers. Until recently the sole available treatment was interferon. After the US Food and Drug Administration (FDA) approved ribavirin, patients who took ribavirin plus interferon responded better. Now, the FDA has approved a small selection of oral antivirals to treat hepatitis C.
Read More
Age-related Diseases Don't Occur Earlier in HIV-infected Patients
November 6th 2014Despite previous research suggesting HIV patients have an increased likelihood of suffering from a heart attack, kidney failure, or cancer, Johns Hopkins Bloomberg School of Public Health investigators showed the age they encounter these conditions were similar to their uninfected counterparts.
Read More